Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy

Leonora W. de Boo(The Netherlands Cancer Institute), Ashley Cimino‐Mathews(Johns Hopkins Hospital), Yoni Lubeck(The Netherlands Cancer Institute), Antonios Daletzakis(The Netherlands Cancer Institute), Mark Opdam(The Netherlands Cancer Institute), Joyce Sanders(The Netherlands Cancer Institute), Erik Hooijberg(The Netherlands Cancer Institute), Annelot van Rossum(The Netherlands Cancer Institute), Zuzana Loncová(Innsbruck Medical University), Dietmar Rieder(Innsbruck Medical University), Zlatko Trajanoski(Innsbruck Medical University), Marieke A. Vollebergh(The Netherlands Cancer Institute), Marcelo Sobral‐Leite(The Netherlands Cancer Institute), Koen Van de Vijver(Ghent University Hospital), Annegien Broeks(The Netherlands Cancer Institute), R Wiel(The Netherlands Cancer Institute), Harm van Tinteren(The Netherlands Cancer Institute), Sabine C. Linn(The Netherlands Cancer Institute), Hugo M. Horlings(The Netherlands Cancer Institute), Marleen Kok(The Netherlands Cancer Institute)
European Journal of Cancer
January 16, 2020
Cited by 28

Abstract


Related Papers

No related papers found

Powered by citation graph analysis